<HashMap><database>NODE</database><scores/><additional><omics_type>Transcriptomics</omics_type><submitter>Pengcheng Zhang</submitter><technology_type>RNA-Seq</technology_type><full_dataset_link>https://www.biosino.org/node/experiment/detail/OEX00010736</full_dataset_link><experiment_platform>Illumina NovaSeq 6000</experiment_platform><experiment_library_layout>Paired</experiment_library_layout><experiment_library_selection>cDNA</experiment_library_selection><sample_count>1</sample_count><tissue>['breast']</tissue><taxonomy>['Mus musculus']</taxonomy><experiment_protocol>4T1 cells were cultured in RPMI1640 containing 10% FBS, 2.5 g L-1 glucose, 0.11 g L-1 sodium pyruvate, and 1% antibiotics. 4T1 tumours were initiated by injecting 100 μL of cells (1,000,000 cells) to the second right mammary gland of female BALB/c mice. Orthotopic 4T1 tumours were treated with 3 injections (i.t.) of either PBS or ORY-1001, and the tumours were harvested 3 days after the last injection.</experiment_protocol><repository>NODE</repository></additional><is_claimable>false</is_claimable><name>ORY-1001 effect in 4T1</name><description>RNA-seq on the effect of lysine-specific histone demethylase 1 inhibitor on 4T1 tumour.</description><dates><publication>2020-10-20</publication><submission>2020-10-20</submission></dates><accession>OEX00010736</accession><cross_references><NODE>OEP00001232</NODE></cross_references></HashMap>